Home / Comparisons / Collagen Peptides vs Topical Peptides: What Studies Show
Collagen Peptides vs Topical Peptides: What Studies Show
Oral collagen is a supplement; peptide creams are cosmetics. How their evidence compares, why no trial pits them against each other, and each one's limits.
On this page
Side by side
| Question | Collagen peptides | Topical cosmetic peptides |
|---|---|---|
| U.S. status | ||
| Strongest evidence | Limited human data | Limited human data |
| Status verified |
Oral collagen and peptide creams both promise better skin, but they are different products, regulated in different ways and tested in different numbers of trials. No study has put them head to head.
Key takeaways
- No trial has compared oral collagen with topical peptides directly. Any comparison on this page is a comparison of the evidence for each, not of results from the same people.
- Oral collagen has many more trials, and the pooled results are disputed. Pooled trials of oral collagen look positive, but in one 2025 meta-analysis the effect disappeared in higher-quality and non-industry-funded studies.
- Topical peptides have a few small, short trials, several of them on formulas with more than one active ingredient.
- Neither is FDA-approved, and neither needs to be. Oral collagen is a dietary supplement; peptide creams are cosmetics.
- Only oral collagen has a meta-analysis for knee osteoarthritis pain that we found. We found no such trial of creams.
How do the two products differ?
| Oral collagen peptides | Topical peptides | |
|---|---|---|
| What it is | Hydrolyzed (broken-down) collagen, taken by mouth | Short chains of amino acids in creams and serums, such as palmitoyl pentapeptide and acetyl hexapeptide-3 |
| How it is sold | As a dietary supplement | As a cosmetic |
| FDA approval before sale | None. FDA does not have authority to approve dietary supplements before they are sold | None. The law does not require FDA approval before cosmetics are sold |
| Safety responsibility | The manufacturer | The company; the MoCRA law adds registration, listing, adverse-event reporting and safety substantiation |
| Where FDA draws a line | Not covered here | A product intended to “remove wrinkles or increase the skin’s production of collagen” is a drug or a device in FDA’s view |
Sources: FDA on supplements, FDA on cosmetics, FDA on wrinkle claims and MoCRA.
Collagen peptides are sold as dietary supplements, which FDA does not approve before they are sold. So “not FDA-approved” is accurate for both products, but it does not mean what it means for an unapproved injectable such as BPC-157: neither goes through that approval at all. For how the legal categories fit together, see are peptides legal in the US.
Which has more evidence?
Oral collagen, by volume. That is not the same as better evidence.
| Evidence | Oral collagen | Topical peptides |
|---|---|---|
| Summaries of randomized trials | Am J Med 2025: 23 trials, 1,474 people. Nutrients 2023: 26 trials, 1,721 people | None for topical peptides alone that we could read |
| Individual trials we read | Many, pooled in the reviews | Six small trials, listed below |
| Result | Pooled: better hydration, elasticity and wrinkles. In the 2025 analysis, no effect in studies without industry funding or in high-quality studies | Wrinkle or roughness improvements reported in small, short trials |
| Main weakness | Disputed once quality and funding are considered; products, doses and measures differ | Small and short; several formulas had more than one active ingredient |
How did the 2025 oral collagen analysis reach its conclusion?
The Am J Med meta-analysis pooled 23 randomized trials with 1,474 participants. The combined result was positive for hydration, elasticity and wrinkles. But it found no effect in studies without industry funding and none in high-quality studies. The authors conclude there is no clinical evidence supporting its use to prevent or treat skin aging. That is one analysis, so it does not settle the question, and it means “meta-analyses show it works” is an incomplete summary. The Nutrients 2023 analysis found better hydration and elasticity and identified biases.
What are the topical peptide trials?
| Ingredient | Trial | What it reported | Limits |
|---|---|---|---|
| Palmitoyl pentapeptide | Robinson 2005: 93 women, 12 weeks, split-face | Wrinkle improvement vs the base moisturizer | Only Caucasian women aged 35 to 55; no size of effect in the abstract |
| Acetyl hexapeptide-3 | Wang 2013: 60 people, 4 weeks | Less roughness around the eyes | Short, small, a small control group |
| Acetyl hexapeptide-3 and palmitoyl pentapeptide-4 | 2023: 21 women, 8 weeks | “Improvements in several subjects” | Very small; the authors call it an initial study |
| Tetrapeptide-68 | 2024: 25 people, 12 weeks | Fewer roughness-based wrinkles | Small; one author worked for the company A&PEP Inc.; funding is not in the abstract |
| Cyclized hexapeptide-9 | 2025: 56 days, vs retinol and vehicle | Lower number, area and roughness of wrinkles | Retinol at 0.002%, which is not comparable with common retinoid products; number and funding not in the abstract |
A serum with several peptides also reported better expression lines in a 55-woman trial funded by Revision Skincare, but it is a mixture, so we cannot credit it to one peptide. For the details of each ingredient, see our guide to skincare peptides.
What does the one review that pools both say?
A 2026 meta-analysis of 19 randomized trials (1,341 people) of oral and topical peptides found a modest effect on wrinkles (a mean difference of 0.27), driven by the oral products. Elasticity and density were inconsistent. It does not separate the topical effect well, so it does not let us compare the two. Its abstract does not limit the oral products to collagen.
Can the two be compared?
Not directly. Reasons:
- No trial compared them. Different people, different durations, different outcomes.
- Different measures. The oral trials report hydration, elasticity and wrinkles. The topical trials report roughness, wrinkle counts and self-rated effects, often around the eyes.
- Different weaknesses. The oral evidence is large but disputed by quality and funding. The topical evidence is small.
- Different claims. Oral collagen has been studied for skin and, in knee osteoarthritis, for pain. Creams that claim to increase collagen production are making the kind of claim FDA gives as an example of a drug claim.
Does either help with joints?
We found studies of this only for oral collagen. A 2023 meta-analysis of collagen peptides in knee osteoarthritis found pain relief (a standardized mean difference of −0.58, 95% CI −0.98 to −0.18), with heterogeneity and biases, and its authors asked for better trials. We reviewed no trials of topical peptides for joints. For other peptides and knee pain, see our guide to peptides for joint pain. We did not review oral collagen for muscle.
What are the risks?
- Oral collagen. It was well tolerated in the meta-analyses. In the knee osteoarthritis analysis, the odds of adverse events were 1.66 (95% CI 0.99 to 2.78), from very low-quality evidence. FDA does not check supplements before sale, and we did not systematically review contaminants or allergies, so we do not say it has no risks.
- Topical peptides. They were well tolerated in the studies above, but the samples were small and short. In a product with several ingredients, a reaction could come from any of them.
- Neither tells you about injectable peptides. Those are different products, and FDA has raised safety concerns about several of them.
Which claims are not supported?
- “Collagen in a cream rebuilds your collagen.” A laboratory finding, and the kind of claim FDA gives as an example of a drug claim.
- “Collagen you swallow goes straight to your skin.” We did not review whether it does, and a lab finding does not show younger-looking skin.
- “Clinically proven.” The data come from different products and formulas.
- “Oral collagen is better than creams” or the reverse. No trial has compared them.
- “Approved by FDA.” Neither is approved.
What should you ask your doctor or dermatologist?
- What is behind the skin changes or joint pain I’m worried about, and which approved treatments exist?
- If I try a supplement or a cream, which ingredient is it, and is there a trial on that product or ingredient?
- Could it interact with medicines I take, or irritate my skin?
- How would we tell if it’s working, and when would we stop?
We do not give doses, and we do not recommend products or brands.
Frequently asked questions
Is oral collagen better than peptide creams?
We do not know. No trial has compared oral collagen with topical peptides directly. Oral collagen has far more trials, but pooled results are disputed once study quality and funding are considered.
Do collagen supplements work for skin?
Pooled trials of oral collagen look positive, but in one 2025 meta-analysis the effect disappeared in higher-quality and non-industry-funded studies.
Do peptide creams work for wrinkles?
Some single-ingredient creams were reported to improve wrinkles in small, short trials. The evidence is thin.
Are collagen supplements or peptide creams FDA-approved?
No, and neither needs to be. FDA does not approve dietary supplements before they are sold, and the law does not require FDA approval before cosmetics are sold.
Can I use both?
We found no trial that tested the two together. Ask your dermatologist about your skin and the products you use.
From Best Peptides Today
Sources we checked
- Oral collagen and skin aging: meta-analysis of 23 randomized trials, Am J Med 2025 (PubMed)PubMed. Accessed .
- Oral collagen and skin: meta-analysis of 26 randomized trials, Nutrients 2023 (PubMed)PubMed. Accessed .
- Meta-analysis of oral and topical peptides for skin aging, Front Med 2026 (PubMed)PubMed. Accessed .
- Collagen peptides in knee osteoarthritis: meta-analysis, 2023 (PubMed)PubMed. Accessed .
- Palmitoyl pentapeptide split-face trial, Robinson 2005 (PubMed)PubMed. Accessed .
- Acetyl hexapeptide trial, Wang 2013 (PubMed)PubMed. Accessed .
- Acetyl hexapeptide-3 and palmitoyl pentapeptide-4 trial, 2023 (PubMed)PubMed. Accessed .
- Tetrapeptide-68 trial, 2024, Pharmaceutics (PubMed)PubMed. Accessed .
- Cyclized hexapeptide-9 trial, 2025, J Cosmet Dermatol (PubMed)PubMed. Accessed .
- FDA: questions and answers on dietary supplementsFDA. Accessed .
- FDA: FDA authority over cosmetics: how cosmetics are not FDA-approved, but are FDA-regulatedFDA. Accessed .
- FDA: wrinkle treatments and other anti-aging productsFDA. Accessed .
- FDA: Modernization of Cosmetics Regulation Act of 2022 (MoCRA)FDA. Accessed .
Written and maintained by the Best Peptides For Editorial Team. How we rate evidence.